Published in Surgery on April 26, 2007
Hyperparathyroidism and malnutrition with severe vitamin D deficiency. World J Surg (2009) 0.93
Long-term changes in parathyroid function after subtotal thyroidectomy for graves' disease. World J Surg (2008) 0.93
Peer-reviewed, evidence-based analysis of vitamin D and primary hyperparathyroidism. World J Surg (2009) 0.89
Eucalcemic parathyroid hormone elevation after parathyroidectomy for primary sporadic hyperparathyroidism: risk factors, trend, and outcome. Ann Surg Oncol (2011) 0.84
Normalization of 2-week postoperative parathyroid hormone values in patients with primary hyperparathyroidism: four-gland exploration compared to focused-approach surgery. World J Surg (2010) 0.79
Justified follow-up: a final intraoperative parathyroid hormone (ioPTH) Over 40 pg/mL is associated with an increased risk of persistence and recurrence in primary hyperparathyroidism. Ann Surg Oncol (2014) 0.78
Parathyroidectomy: is vitamin D a player for a good outcome? J Med Life (2016) 0.75
High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines. Cancer Res (2003) 2.49
Effect of the vascular endothelial growth factor receptor-2 antibody DC101 plus gemcitabine on growth, metastasis and angiogenesis of human pancreatic cancer growing orthotopically in nude mice. Int J Cancer (2002) 2.12
Surgeon-performed ultrasound can predict differentiated thyroid cancer in patients with solitary thyroid nodules. Ann Surg Oncol (2009) 2.09
Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate? Surgery (2003) 2.03
Thyroid cancer: is the incidence still increasing? Ann Surg Oncol (2004) 1.82
DNA methylation profiling identifies global methylation differences and markers of adrenocortical tumors. J Clin Endocrinol Metab (2012) 1.67
Thyroidectomy remains an effective treatment option for Graves' disease. Am J Surg (2006) 1.67
Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors. Surgery (2013) 1.62
Are pANCA, ASCA, or cytokine gene polymorphisms associated with pouchitis? Long-term follow-up in 102 ulcerative colitis patients. Am J Gastroenterol (2004) 1.50
Quick intraoperative parathyroid hormone assay: surgical adjunct to allow limited parathyroidectomy, improve success rate, and predict outcome. World J Surg (2004) 1.32
Are there gender differences in choosing a surgical career? Surgery (2003) 1.28
Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations. Cancer (2005) 1.26
Blockade of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling for therapy of metastatic human pancreatic cancer. Cancer Res (2002) 1.23
Long-term survival after surgical management of neuroendocrine hepatic metastases. HPB (Oxford) (2010) 1.17
Surgical treatment of non-functioning pancreatic islet cell tumors. J Surg Oncol (2005) 1.16
Fine needle aspiration of the thyroid: correlation with final histopathology in a surgical series of 797 patients. J Am Coll Surg (2011) 1.16
Intraoperative parathyroid hormone levels in thyroid surgery are predictive of postoperative hypoparathyroidism and need for vitamin D supplementation. Am J Surg (2005) 1.16
Heparanase-1 expression is associated with the metastatic potential of breast cancer. Surgery (2002) 1.10
Heparanase-1 gene expression and regulation by high glucose in renal epithelial cells: a potential role in the pathogenesis of proteinuria in diabetic patients. Diabetes (2005) 1.10
Cloning and characterization of the human heparanase-1 (HPR1) gene promoter: role of GA-binding protein and Sp1 in regulating HPR1 basal promoter activity. J Biol Chem (2002) 1.09
Surgical management of primary hyperparathyroidism: state of the art. Surg Clin North Am (2009) 1.06
Incidental papillary carcinoma in patients treated surgically for benign thyroid diseases. Surgery (2009) 1.05
Major histocompatibility complex class I-related chain A/B (MICA/B) expression in tumor tissue and serum of pancreatic cancer: role of uric acid accumulation in gemcitabine-induced MICA/B expression. BMC Cancer (2011) 1.04
Management of biliary and duodenal complications of chronic pancreatitis. World J Surg (2003) 1.03
A CRASH course in procedural skills improves medical students' self-assessment of proficiency, confidence, and anxiety. Am J Surg (2007) 1.03
Progress in the operative management of sporadic primary hyperparathyroidism over 34 years. Ann Surg (2004) 1.00
Medical students' perceptions of resident teaching: have duty hours regulations had an impact? Ann Surg (2005) 0.99
Role of intraoperative parathormone monitoring during parathyroidectomy in patients with discordant localization studies. Surgery (2008) 0.98
Resident education in 2011: three key challenges on the road ahead. Surgery (2011) 0.98
Somatostatin analog treatment of a cervical thoracic duct fistula. Head Neck (2002) 0.98
Elevated serum heparanase-1 levels in patients with pancreatic carcinoma are associated with poor survival. Cancer (2006) 0.97
Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis. Clin Cancer Res (2003) 0.96
What is the best criterion for the interpretation of adrenal vein sample results in patients with primary hyperaldosteronism? Ann Surg Oncol (2011) 0.95
Surgeon-performed ultrasound: a single institution experience in parathyroid localization. Surgery (2009) 0.95
Human heparanase-1 gene expression in pancreatic adenocarcinoma. J Gastrointest Surg (2002) 0.95
Central pancreatectomy for the resection of benign or low malignant potential neoplasms. World J Surg (2003) 0.94
Outcome of laparoscopic adrenalectomy for pheochromocytomas vs aldosteronomas. Arch Surg (2004) 0.94
Operative failure in the era of focused parathyroidectomy: a contemporary series of 845 patients. Arch Surg (2010) 0.93
Parathyroidectomy outcomes according to operative approach. Am J Surg (2007) 0.93
Developments in the use of ultrasound for thyroid cancer. Curr Opin Oncol (2010) 0.93
Intraoperative PTH monitoring in parathyroid hyperplasia requires stricter criteria for success. Surgery (2004) 0.92
Sporadic primary hyperparathyroidism in young individuals: different disease and treatment? J Surg Res (2008) 0.91
The presence of SDHB mutations should modify surgical indications for carotid body paragangliomas. Ann Surg (2014) 0.91
Benefits of surgeon-performed ultrasound for primary hyperparathyroidism. Langenbecks Arch Surg (2009) 0.91
Adrenocorticotropic hormone-secreting pancreatic islet cell carcinoma. J Am Coll Surg (2004) 0.91
MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors. Surgery (2013) 0.91
Genome-wide methylation patterns in papillary thyroid cancer are distinct based on histological subtype and tumor genotype. J Clin Endocrinol Metab (2013) 0.90
Activation of the Sonic Hedgehog pathway in thyroid neoplasms and its potential role in tumor cell proliferation. Endocr Relat Cancer (2012) 0.90
Long-term results of parathyroidectomy for hypercalcemic crisis. Arch Surg (2006) 0.89
Primary hyperaldosteronism in the era of laparoscopic adrenalectomy. Am Surg (2002) 0.89
An algorithm to maximize use of minimally invasive parathyroidectomy. Arch Surg (2004) 0.89
Consequences of targeted parathyroidectomy guided by localization studies without intraoperative parathyroid hormone monitoring. J Am Coll Surg (2006) 0.89
In vivo and in vitro degradation of heparan sulfate (HS) proteoglycans by HPR1 in pancreatic adenocarcinomas. Loss of cell surface HS suppresses fibroblast growth factor 2-mediated cell signaling and proliferation. J Biol Chem (2006) 0.89
Complete androgen insensitivity syndrome: the role of the endocrine surgeon. Am Surg (2005) 0.89
Toxic nodular goiter and cancer: a compelling case for thyroidectomy. Ann Surg Oncol (2012) 0.88
The sonic hedgehog signaling pathway maintains the cancer stem cell self-renewal of anaplastic thyroid cancer by inducing snail expression. J Clin Endocrinol Metab (2014) 0.88
Rate of clinically significant postoperative pancreatic fistula in pancreatic neuroendocrine tumors. World J Surg (2012) 0.88
Is potassium iodide solution necessary before total thyroidectomy for Graves disease? Ann Surg Oncol (2013) 0.88
Greater local recurrence occurs with "berry picking" than neck dissection in thyroid cancer. Am Surg (2003) 0.87
Quantitative high-throughput drug screening identifies novel classes of drugs with anticancer activity in thyroid cancer cells: opportunities for repurposing. J Clin Endocrinol Metab (2011) 0.87
Predictors of hemodynamic instability during surgery for pheochromocytoma. Ann Surg Oncol (2014) 0.86
Estradiol induces heparanase-1 expression and heparan sulphate proteoglycan degradation in human endometrium. Hum Reprod (2007) 0.86
Ductal carcinoma in situ of the breast and heparanase-1 expression: a molecular explanation for more aggressive subtypes. J Am Coll Surg (2005) 0.86
Response after surgical resection of metastatic pheochromocytoma and paraganglioma: can postoperative biochemical remission be predicted? J Am Coll Surg (2013) 0.86
Association of type O blood with pancreatic neuroendocrine tumors in Von Hippel-Lindau syndrome. Ann Surg Oncol (2012) 0.86
Use of ultrasound in the management of thyroid cancer. Oncologist (2010) 0.86
Impact of surgical mentorship on retroperitoneoscopic adrenalectomy with comparison to transperitoneal laparoscopic adrenalectomy. Am Surg (2013) 0.85
Surgical management of well-differentiated thyroid cancer locally invasive to the respiratory tract. J Am Coll Surg (2005) 0.84
Intraoperative total serum calcium levels, unlike intraoperative intact PTH levels, do not correlate with cure of hyperparathyroidism. J Surg Res (2003) 0.84
Comparison of 6-18F-fluoro-L-DOPA, 18F-2-deoxy-D-glucose, CT, and MRI in patients with pancreatic neuroendocrine neoplasms with von Hippel-Lindau disease. Surgery (2011) 0.84
Clinicopathological significance of major histocompatibility complex class I-related chain a and B expression in thyroid cancer. J Clin Endocrinol Metab (2006) 0.84
Pheochromocytoma presenting with multiple organ failure. Am Surg (2008) 0.84
Interleukin-13 receptor alpha2 is a novel therapeutic target for human adrenocortical carcinoma. Cancer (2012) 0.84
Sleeping parathyroid tumor: rapid hyperfunction after removal of the dominant tumor. J Clin Endocrinol Metab (2012) 0.83
Metastatic choriocarcinoma to the pancreas. Am Surg (2005) 0.83
A prospective evaluation of the effect of sample collection site on intraoperative parathormone monitoring during parathyroidectomy. Surgery (2008) 0.83
Cholestasis secondary to hyperthyroidism made worse by methimazole. Am J Med Sci (2006) 0.83
Are patients of low socioeconomic status receiving suboptimal management for pancreatic adenocarcinoma? Cancer (2010) 0.83
Short-term outcomes of parathyroidectomy in patients with or without 25-hydroxy vitamin D insufficiency. J Surg Res (2007) 0.82
Induction of heparanase-1 expression by mutant B-Raf kinase: role of GA binding protein in heparanase-1 promoter activation. Neoplasia (2010) 0.82
Clinical utility of functional imaging with ¹⁸F-FDOPA in Von Hippel-Lindau syndrome. J Clin Endocrinol Metab (2012) 0.82
Innate immune receptor genetic polymorphisms in pouchitis: is CARD15 a susceptibility factor? Inflamm Bowel Dis (2005) 0.82
von Hippel-Lindau disease-associated solid microcystic serous adenomas masquerading as pancreatic neuroendocrine neoplasms. Surgery (2012) 0.82
Association of type-O blood with neuroendocrine tumors in multiple endocrine neoplasia type 1. J Clin Endocrinol Metab (2012) 0.81
Outcomes of pheochromocytoma management in the laparoscopic era. Ann Surg Oncol (2007) 0.81
CA 19-9 nonproduction is associated with poor survival after resection of pancreatic adenocarcinoma. Am J Clin Oncol (2014) 0.81
Recurrent disease after limited parathyroidectomy for sporadic primary hyperparathyroidism. J Am Coll Surg (2004) 0.81
Trends in thyroid surgery in Illinois. Surgery (2013) 0.80
Same-day ultrasound guidance in reoperations for locally recurrent papillary thyroid cancer. Surgery (2007) 0.80
Expense of robotic thyroidectomy: a cost analysis at a single institution. Arch Surg (2012) 0.80
Vascular complications associated with pancreaticoduodenectomy adversely affect clinical outcome. Surgery (2002) 0.80